annual CFF:
-$11.74B+$2.54B(+17.76%)Summary
- As of today (May 21, 2025), NVS annual cash flow from financing activities is -$11.74 billion, with the most recent change of +$2.54 billion (+17.76%) on December 31, 2024.
- During the last 3 years, NVS annual CFF has risen by +$4.52 billion (+27.80%).
- NVS annual CFF is now -385.28% below its all-time high of $4.12 billion, reached on December 31, 2010.
Performance
NVS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$8.55B-$5.55B(-185.31%)Summary
- As of today (May 21, 2025), NVS quarterly cash flow from financing activities is -$8.55 billion, with the most recent change of -$5.55 billion (-185.31%) on March 31, 2025.
- Over the past year, NVS quarterly CFF has dropped by -$3.38 billion (-65.53%).
- NVS quarterly CFF is now -218.66% below its all-time high of $7.20 billion, reached on September 30, 2010.
Performance
NVS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$15.13B-$3.38B(-28.82%)Summary
- As of today (May 21, 2025), NVS TTM cash flow from financing activities is -$15.13 billion, with the most recent change of -$3.38 billion (-28.82%) on March 31, 2025.
- Over the past year, NVS TTM CFF has dropped by -$4.89 billion (-47.71%).
- NVS TTM CFF is now -288.25% below its all-time high of $8.04 billion, reached on September 30, 2010.
Performance
NVS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.8% | -65.5% | -47.7% |
| 3 y3 years | +27.8% | +10.3% | +12.3% |
| 5 y5 years | +13.8% | -943.8% | -416.1% |
NVS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.9% | -2137.7% | +10.3% | -61.7% | +29.9% |
| 5 y | 5-year | -431.8% | +42.9% | -549.9% | +10.3% | -3084.4% | +29.9% |
| alltime | all time | -385.3% | +42.9% | -218.7% | +11.7% | -288.3% | +29.9% |
NVS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$8.55B(+185.3%) | -$15.13B(+28.8%) |
| Dec 2024 | -$11.74B(-17.8%) | -$3.00B(+684.3%) | -$11.74B(+25.5%) |
| Sep 2024 | - | -$382.00M(-88.1%) | -$9.35B(-4.6%) |
| Jun 2024 | - | -$3.20B(-38.0%) | -$9.80B(-4.3%) |
| Mar 2024 | - | -$5.16B(+750.7%) | -$10.24B(-28.3%) |
| Dec 2023 | -$14.28B(-30.6%) | -$607.00M(-27.0%) | -$14.28B(-19.2%) |
| Sep 2023 | - | -$832.00M(-77.1%) | -$17.66B(-18.1%) |
| Jun 2023 | - | -$3.64B(-60.5%) | -$21.57B(+6.6%) |
| Mar 2023 | - | -$9.20B(+130.4%) | -$20.24B(-1.6%) |
| Dec 2022 | -$20.56B(+26.4%) | -$3.99B(-15.7%) | -$20.56B(+3.7%) |
| Sep 2022 | - | -$4.74B(+105.8%) | -$19.82B(+19.3%) |
| Jun 2022 | - | -$2.30B(-75.8%) | -$16.61B(-3.7%) |
| Mar 2022 | - | -$9.53B(+193.1%) | -$17.25B(+6.1%) |
| Dec 2021 | -$16.26B(+636.6%) | -$3.25B(+111.9%) | -$16.26B(+2.0%) |
| Sep 2021 | - | -$1.53B(-47.8%) | -$15.95B(+27.4%) |
| Jun 2021 | - | -$2.94B(-65.6%) | -$12.52B(+6.4%) |
| Mar 2021 | - | -$8.54B(+190.9%) | -$11.76B(+432.7%) |
| Dec 2020 | -$2.21B(-83.8%) | -$2.94B(-254.5%) | -$2.21B(+364.8%) |
| Sep 2020 | - | $1.90B(-187.0%) | -$475.00M(-90.7%) |
| Jun 2020 | - | -$2.19B(-315.7%) | -$5.09B(+73.6%) |
| Mar 2020 | - | $1.01B(-184.2%) | -$2.93B(-78.5%) |
| Dec 2019 | -$13.63B(+221.1%) | -$1.20B(-55.7%) | -$13.63B(+13.8%) |
| Sep 2019 | - | -$2.71B(+9589.3%) | -$11.97B(+10.0%) |
| Jun 2019 | - | -$28.00M(-99.7%) | -$10.88B(-12.1%) |
| Mar 2019 | - | -$9.68B(-2237.5%) | -$12.38B(+191.7%) |
| Dec 2018 | -$4.24B(-45.1%) | $453.00M(-127.9%) | -$4.24B(-40.2%) |
| Sep 2018 | - | -$1.62B(+5.9%) | -$7.09B(-4.3%) |
| Jun 2018 | - | -$1.53B(-1.0%) | -$7.41B(-16.7%) |
| Mar 2018 | - | -$1.55B(-35.5%) | -$8.89B(+15.0%) |
| Dec 2017 | -$7.73B(+45.5%) | -$2.40B(+23.7%) | -$7.73B(+1.2%) |
| Sep 2017 | - | -$1.94B(-35.7%) | -$7.64B(+26.4%) |
| Jun 2017 | - | -$3.01B(+676.3%) | -$6.04B(+29.3%) |
| Mar 2017 | - | -$388.00M(-83.2%) | -$4.67B(-12.0%) |
| Dec 2016 | -$5.31B(-42.1%) | -$2.30B(+573.4%) | -$5.31B(-8.2%) |
| Sep 2016 | - | -$342.00M(-79.2%) | -$5.79B(-24.3%) |
| Jun 2016 | - | -$1.64B(+59.9%) | -$7.64B(-9.6%) |
| Mar 2016 | - | -$1.03B(-63.0%) | -$8.45B(-7.9%) |
| Dec 2015 | -$9.18B(+12.6%) | -$2.77B(+26.4%) | -$9.18B(+28.5%) |
| Sep 2015 | - | -$2.20B(-10.4%) | -$7.14B(+18.5%) |
| Jun 2015 | - | -$2.45B(+39.6%) | -$6.03B(-3.0%) |
| Mar 2015 | - | -$1.75B(+136.5%) | -$6.21B(-23.7%) |
| Dec 2014 | -$8.15B(-7.1%) | -$742.00M(-31.3%) | -$8.15B(-8.7%) |
| Sep 2014 | - | -$1.08B(-59.1%) | -$8.92B(-3.4%) |
| Jun 2014 | - | -$2.64B(-28.5%) | -$9.23B(+1.3%) |
| Mar 2014 | - | -$3.69B(+142.9%) | -$9.12B(+4.0%) |
| Dec 2013 | -$8.77B | -$1.52B(+9.1%) | -$8.77B(+4.5%) |
| Sep 2013 | - | -$1.39B(-44.7%) | -$8.39B(-7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$2.52B(-24.6%) | -$9.12B(+10.2%) |
| Mar 2013 | - | -$3.34B(+192.0%) | -$8.27B(+23.9%) |
| Dec 2012 | -$6.67B(-55.6%) | -$1.14B(-46.0%) | -$6.67B(-31.5%) |
| Sep 2012 | - | -$2.12B(+26.6%) | -$9.75B(-14.4%) |
| Jun 2012 | - | -$1.67B(-4.0%) | -$11.39B(-30.0%) |
| Mar 2012 | - | -$1.74B(-58.7%) | -$16.28B(+8.4%) |
| Dec 2011 | -$15.02B(-465.0%) | -$4.22B(+12.2%) | -$15.02B(+1.1%) |
| Sep 2011 | - | -$3.76B(-42.7%) | -$14.86B(+281.1%) |
| Jun 2011 | - | -$6.56B(+1246.4%) | -$3.90B(-208.1%) |
| Mar 2011 | - | -$487.00M(-88.0%) | $3.61B(-12.4%) |
| Dec 2010 | $4.12B(+46.5%) | -$4.06B(-156.4%) | $4.12B(-48.8%) |
| Sep 2010 | - | $7.20B(+658.3%) | $8.04B(+530.7%) |
| Jun 2010 | - | $950.00M(+4218.2%) | $1.27B(-46.4%) |
| Mar 2010 | - | $22.00M(-115.6%) | $2.38B(-15.3%) |
| Dec 2009 | $2.81B(-209.2%) | -$141.00M(-131.8%) | $2.81B(-452.0%) |
| Sep 2009 | - | $443.00M(-78.4%) | -$798.00M(+43.5%) |
| Jun 2009 | - | $2.06B(+354.6%) | -$556.00M(-135.5%) |
| Mar 2009 | - | $452.00M(-112.1%) | $1.57B(-160.9%) |
| Dec 2008 | -$2.57B(-72.4%) | -$3.75B(-647.2%) | -$2.57B(+29.9%) |
| Sep 2008 | - | $685.00M(-83.6%) | -$1.98B(-64.2%) |
| Jun 2008 | - | $4.18B(-213.3%) | -$5.54B(-47.4%) |
| Mar 2008 | - | -$3.69B(+16.9%) | -$10.53B(+13.0%) |
| Dec 2007 | -$9.32B(+89.0%) | -$3.16B(+9.9%) | -$9.32B(+15.5%) |
| Sep 2007 | - | -$2.87B(+254.7%) | -$8.06B(+42.3%) |
| Jun 2007 | - | -$810.00M(-67.3%) | -$5.67B(+0.1%) |
| Mar 2007 | - | -$2.48B(+30.3%) | -$5.66B(+14.8%) |
| Dec 2006 | -$4.93B(+1719.6%) | -$1.90B(+300.6%) | -$4.93B(+300.2%) |
| Sep 2006 | - | -$475.00M(-41.0%) | -$1.23B(-9.0%) |
| Jun 2006 | - | -$805.00M(-53.9%) | -$1.35B(-223.4%) |
| Mar 2006 | - | -$1.75B(-197.3%) | $1.10B(-504.8%) |
| Dec 2005 | -$271.00M(-91.0%) | $1.80B(-400.8%) | -$271.00M(-77.6%) |
| Sep 2005 | - | -$597.00M(-136.3%) | -$1.21B(-18.2%) |
| Jun 2005 | - | $1.65B(-152.8%) | -$1.48B(-61.8%) |
| Mar 2005 | - | -$3.12B(-462.7%) | -$3.86B(+28.8%) |
| Dec 2004 | -$3.00B(-47.7%) | $859.00M(-199.3%) | -$3.00B(-32.1%) |
| Sep 2004 | - | -$865.00M(+16.9%) | -$4.41B(-0.3%) |
| Jun 2004 | - | -$740.00M(-67.1%) | -$4.43B(-29.5%) |
| Mar 2004 | - | -$2.25B(+305.0%) | -$6.28B(+9.5%) |
| Dec 2003 | -$5.73B(+41.8%) | -$556.00M(-36.7%) | -$5.73B(+10.7%) |
| Sep 2003 | - | -$879.00M(-66.1%) | -$5.18B(+20.5%) |
| Jun 2003 | - | -$2.59B(+51.7%) | -$4.30B(+151.7%) |
| Mar 2003 | - | -$1.71B | -$1.71B |
| Dec 2002 | -$4.04B(+2394.4%) | - | - |
| Dec 2001 | -$162.00M(-94.5%) | - | - |
| Dec 2000 | -$2.95B(+8.6%) | - | - |
| Dec 1999 | -$2.71B(+16.2%) | - | - |
| Dec 1998 | -$2.34B | - | - |
FAQ
- What is Novartis AG annual cash flow from financing activities?
- What is the all time high annual CFF for Novartis AG?
- What is Novartis AG annual CFF year-on-year change?
- What is Novartis AG quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Novartis AG?
- What is Novartis AG quarterly CFF year-on-year change?
- What is Novartis AG TTM cash flow from financing activities?
- What is the all time high TTM CFF for Novartis AG?
- What is Novartis AG TTM CFF year-on-year change?
What is Novartis AG annual cash flow from financing activities?
The current annual CFF of NVS is -$11.74B
What is the all time high annual CFF for Novartis AG?
Novartis AG all-time high annual cash flow from financing activities is $4.12B
What is Novartis AG annual CFF year-on-year change?
Over the past year, NVS annual cash flow from financing activities has changed by +$2.54B (+17.76%)
What is Novartis AG quarterly cash flow from financing activities?
The current quarterly CFF of NVS is -$8.55B
What is the all time high quarterly CFF for Novartis AG?
Novartis AG all-time high quarterly cash flow from financing activities is $7.20B
What is Novartis AG quarterly CFF year-on-year change?
Over the past year, NVS quarterly cash flow from financing activities has changed by -$3.38B (-65.53%)
What is Novartis AG TTM cash flow from financing activities?
The current TTM CFF of NVS is -$15.13B
What is the all time high TTM CFF for Novartis AG?
Novartis AG all-time high TTM cash flow from financing activities is $8.04B
What is Novartis AG TTM CFF year-on-year change?
Over the past year, NVS TTM cash flow from financing activities has changed by -$4.89B (-47.71%)